Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Diabetes & Metabolic Disorders
Published in: Journal of Diabetes & Metabolic Disorders 1/2020

01-06-2020 | Type 2 Diabetes | Research article

Assessment of remote patient monitoring (RPM) systems for patients with type 2 diabetes: a systematic review and meta-analysis

Authors: Sahar Salehi, Alireza Olyaeemanesh, Mohammadreza Mobinizadeh, Ensieh Nasli-Esfahani, Hossein Riazi

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2020

Login to get access

Abstract

Introduction

The objective of this study is to conduct an assessment of Remote Patient Monitoring (RPM) systems compared to usual care for controlling glycosylated hemoglobin in type 2 diabetes.

Methods

The study was a systematic review with meta-analysis and meta-regression. A systematic search was performed via the most important electronic databases of medical resources, such as PubMed, Scopus and Cochrane library. The main outcome was HbA1C. The heterogeneity sources were examined using Chi-square (Q) and I2 tests. Meta-analyses were done using Stata version 11 software. Statistical significance was defined as P < 0.05. Random effects model was used in meta-analysis, and the heterogeneity more than 50% was considered as significant.

Results

The results of the systematic review and meta-analysis indicated that the effect size index (Difference of Pre-test/Post-test Control Design-2nd method “using pooled pretest SD” (DPPC2)) among users of RPM for type 2 diabetic patients was −0.32 with a confidence interval of 95% (from −0.45 to −0.19) as compared to the control group. The current study declared a vital role of RPM technology in reduction of hemoglobin glycogen levels. The results of the subgroup analysis showed that RPM is more effective for patients who are residents of cities, having intervention lengths less than 6 months, getting the orders from the physician and using the websites as their intervention type.

Conclusion

The current study indicted the efficacy of RPM in reducing HbA1c among type 2 diabetic patients, which could be a base for policymakers to decide on the introduction of this technology in Iran.
Literature
1.
Logan AG, McIsaac WJ, Tisler A, Irvine MJ, Saunders A, Dunai A, et al. Mobile phone–based remote patient monitoring system for management of hypertension in diabetic patients. Am J Hypertens. 2007;20(9):942–8.PubMed
2.
Organization WH. Global report on diabetes: World Health Organization. Geneva; 2016.
3.
Control CD. Prevention. National diabetes statistics report, 2017. Centers for Disease Control and Prevention, US Department of Health and Human Services.: Atlanta, GA; 2017.
4.
Fathi ahmadsaraei N, Neshat doost HT, Manshaee GR, Nadi MA. The Effectiveness of Acceptance and Commitment Therapy on Quality of Life among Patients with Type 2 Diabetes. Iranian Journal of Health Education and Health Promotion. 2016;4(1):31–9.
5.
Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311–21.PubMed
6.
Organization WH. Use of glycated haemoglobin (HbA1c) in diagnosis of diabetes mellitus: abbreviated report of a WHO consultation. Geneva: World Health Organization; 2011.
7.
Holl F, Munteh P, Burk R, Swoboda W. Improving access to care in rural Africa through the use of telemedicine: Using a mHealth system as a case study. Studies in health technology and informatics. 2017;244:105.
8.
Vegesna A, Tran M, Angelaccio M, Arcona S. Remote patient monitoring via non-invasive digital technologies: a systematic review. Telemedicine and e-Health. 2017;23(1):3–17.PubMed
9.
Chase HP, Pearson JA, Wightman C, Roberts MD, Oderberg AD, Garg SK. Modem transmission of glucose values reduces the costs and need for clinic visits. Diabetes Care. 2003;26(5):1475–9.PubMed
10.
Bonsignore L, Bloom N, Steinhauser K, Nichols R, Allen T, Twaddle M, et al. Evaluating the Feasibility and Acceptability of a Telehealth Program in a Rural Palliative Care Population: TapCloud for Palliative Care. J Pain Symptom Manag. 2018.
11.
Yoo B-K, Kim M, Sasaki T, Hoch JS, Marcin JP. Selected use of telemedicine in intensive care units based on severity of illness improves cost-effectiveness. Telemedicine and e-Health. 2018;24(1):21–36.PubMed
12.
Smith NM, Satyshur RD. Pediatric diabetes telemedicine program improves access to care for rural families: role of APRNs. Pediatr Nurs. 2016;42(6):294.PubMed
13.
Noah B, Keller MS, Mosadeghi S, Stein L, Johl S, Delshad S, et al. Impact of remote patient monitoring on clinical outcomes: an updated meta-analysis of randomized controlled trials. NPJ Digital Medicine. 2018;1(1):2.
14.
Wilson LS, Maeder AJ. Recent directions in telemedicine: review of trends in research and practice. Healthcare informatics research. 2015;21(4):213–22.PubMedPubMedCentral
15.
Bayliss EA, Steiner JF, Fernald DH, Crane LA, Main DS. Descriptions of barriers to self-care by persons with comorbid chronic diseases. The Annals of Family Medicine. 2003;1(1):15–21.PubMed
16.
Coye MJ, Haselkorn A, DeMello S. Remote patient management: technology-enabled innovation and evolving business models for chronic disease care. Health Aff. 2009;28(1):126–35.
17.
18.
Riazi H, Larijani B, Langarizadeh M, Shahmoradi L. Managing diabetes mellitus using information technology: a systematic review. Journal of Diabetes & Metabolic Disorders. 2015;14(1):49.
19.
Onkar Sumant PJ. Remote Patient Monitoring Market by Condition (Congestive Heart Failure, Diabetes, Chronic Obstructive Pulmonary Disease, Blood Pressure, and Mental Health), Components (Devices and Software) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022. 2016.
20.
Global Remote Patient Monitoring Systems Market. 2017.
21.
Baum P, Abadie F, Lupiañez FV, Maghiros I, Mora EV, Talaya MBZ. Market Developments–Remote Patient Monitoring and Treatment, Telecare, Fitness/Wellness and mHealth. Strategic Intelligence Monitor on Personal Health Systems, Phase. 2013;2.
22.
Hossain MS, editor. Patient status monitoring for smart home healthcare. Multimedia & Expo Workshops (ICMEW), 2016 IEEE International Conference on; 2016: IEEE.
23.
24.
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. 2010.
25.
Morris SB. Estimating effect sizes from pretest-posttest-control group designs. Organ Res Methods. 2008;11(2):364–86.
26.
Kwon H-S, Cho J-H, Kim H-S, Song B-R, Ko S-H, Lee J-M, et al. Establishment of blood glucose monitoring system using the internet. Diabetes Care. 2004;27(2):478–83.PubMed
27.
Cho J-H, Chang S-A, Kwon H-S, Choi Y-H, Ko S-H, Moon S-D, et al. Long-term effect of the Internet-based glucose monitoring system on HbA1c reduction and glucose stability: a 30-month follow-up study for diabetes management with a ubiquitous medical care system. Diabetes Care. 2006;29(12):2625–31.PubMed
28.
Shea S, Weinstock RS, Starren J, Teresi J, Palmas W, Field L, et al. A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus. J Am Med Inform Assoc. 2006;13(1):40–51.PubMedPubMedCentral
29.
Tildesley HD, Mazanderani AB, Ross SA. Effect of Internet therapeutic intervention on A1C levels in patients with type 2 diabetes treated with insulin. Diabetes Care. 2010;33(8):1738–40.PubMedPubMedCentral
30.
Quinn CC, Shardell MD, Terrin ML, Barr EA, Ballew SH, Gruber-Baldini AL. Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control. Diabetes Care. 2011;34(9):1934–42.PubMedPubMedCentral
31.
Kleinman NJ, Shah A, Shah S, Phatak S, Viswanathan V. Improved medication adherence and frequency of blood glucose self-testing using an m-Health platform versus usual care in a multisite randomized clinical trial among people with type 2 diabetes in India. Telemedicine and e-Health. 2017;23(9):733–40.PubMed
32.
Warren R, Carlisle K, Mihala G, Scuffham PA. Effects of telemonitoring on glycaemic control and healthcare costs in type 2 diabetes: a randomised controlled trial. J Telemed Telecare. 2018;24(9):586–95.PubMed
33.
Bujnowska-Fedak MM, Puchała E, Steciwko A. The impact of telehome care on health status and quality of life among patients with diabetes in a primary care setting in Poland. Telemedicine and e-Health. 2011;17(3):153–63.PubMed
34.
Tang PC, Overhage JM, Chan AS, Brown NL, Aghighi B, Entwistle MP, et al. Online disease management of diabetes: engaging and motivating patients online with enhanced resources-diabetes (EMPOWER-D), a randomized controlled trial. J Am Med Inform Assoc. 2012;20(3):526–34.PubMedPubMedCentral
35.
Istepanian RS, Mousa A, Haddad N, Sungoor A, Hammadan T, Soran H et al., editors. The potential of m-health systems for diabetes management in post conflict regions a case study from Iraq. 2014 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society; 2014: IEEE.
36.
Steventon A, Bardsley M, Doll H, Tuckey E, Newman SP. Effect of telehealth on glycaemic control: analysis of patients with type 2 diabetes in the Whole Systems Demonstrator cluster randomised trial. BMC Health Serv Res. 2014;14(1):334.PubMedPubMedCentral
37.
Wakefield BJ, Koopman RJ, Keplinger LE, Bomar M, Bernt B, Johanning JL, et al. Effect of home telemonitoring on glycemic and blood pressure control in primary care clinic patients with diabetes. Telemedicine and e-Health. 2014;20(3):199–205.PubMed
38.
Fountoulakis S, Papanastasiou L, Gryparis A, Markou A, Piaditis G. Impact and duration effect of telemonitoring on HbA1c, BMI and cost in insulin-treated Diabetes Mellitus patients with inadequate glycemic control: A randomized controlled study. Hormones. 2015;14(4):632–43.PubMed
39.
Zhai Y-k, Zhu W-j, Cai Y-l, Sun D-x, Zhao J. Clinical-and cost-effectiveness of telemedicine in type 2 diabetes mellitus: a systematic review and meta-analysis. Medicine. 2014;93(28).
40.
Nicolucci A, Cercone S, Chiriatti A, Muscas F, Gensini G, Group RS. A randomized trial on home telemonitoring for the management of metabolic and cardiovascular risk in patients with type 2 diabetes. Diabetes Technol Ther. 2015;17(8):563–70.PubMed
41.
42.
Anzaldo-Campos MC, Contreras S, Vargas-Ojeda A, Menchaca-Diaz R, Fortmann A, Philis-Tsimikas A. Dulce Wireless Tijuana: a Randomized Control Trial Evaluating the Impact of Project Dulce and Short-Term Mobile Technology on Glycemic Control in a Family Medicine Clinic in Northern Mexico. Diabetes Technol Ther. 2016;18(4):240–51. https://​doi.​org/​10.​1089/​dia.​2015.​0283.PubMedPubMedCentral
43.
Holmen H, Torbjørnsen A, Wahl AK, Jenum AK, Småstuen MC, Årsand E, et al. A mobile health intervention for self-management and lifestyle change for persons with type 2 diabetes, part 2: One-year results from the Norwegian randomized controlled trial RENEWING HEALTH. Diabetes Technology and Therapeutics. 2016;18:S58–S9. https://​doi.​org/​10.​1089/​dia.​2016.​2506.
44.
45.
Cho JH, Kim HS, Yoo SH, Jung CH, Lee WJ, Park CY, et al. An Internet-based health gateway device for interactive communication and automatic data uploading: Clinical efficacy for type 2 diabetes in a multi-centre trial. J Telemed Telecare. 2017;23(6):595–604. https://​doi.​org/​10.​1177/​1357633X16657500​.PubMed
46.
Dario C, Toffanin R, Calcaterra F, Saccavini C, Stafylas P, Mancin S, et al. Telemonitoring of Type 2 Diabetes Mellitus in Italy. Telemedicine journal and e-health: the official journal of the American Telemedicine Association. 2017;23(2):143–52. https://​doi.​org/​10.​1089/​tmj.​2015.​0224.
47.
Kitsiou S, Pare G, Jaana M, Gerber B. Effectiveness of mHealth interventions for patients with diabetes: an overview of systematic reviews. PLoS One. 2017;12(3):e0173160.PubMedPubMedCentral
48.
Saffari M, Ghanizadeh G, Koenig HG. Health education via mobile text messaging for glycemic control in adults with type 2 diabetes: a systematic review and meta-analysis. Primary care diabetes. 2014;8(4):275–85.PubMed
49.
Shabaninejad H, Sarikhani M, Asgharzadeh A. Investigating the effect of providing care thrugh a text message of a cell phone in comparison with the face-to-face approach for controlling blood glucose (HBA1C) in patients with type 2 diabetes: A systematic review and analysis of meta_regression. Iranian Journal of Diabetes and Metabolism. 2018;17(6):272–84.
Metadata
Title
Assessment of remote patient monitoring (RPM) systems for patients with type 2 diabetes: a systematic review and meta-analysis
Authors
Sahar Salehi
Alireza Olyaeemanesh
Mohammadreza Mobinizadeh
Ensieh Nasli-Esfahani
Hossein Riazi
Publication date
01-06-2020
Publisher
Springer International Publishing
Keyword
Type 2 Diabetes
Published in
Journal of Diabetes & Metabolic Disorders / Issue 1/2020
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-019-00482-3

Other articles of this Issue 1/2020

Journal of Diabetes & Metabolic Disorders 1/2020 Go to the issue

Research article

Identifying spatial variation in the burden of diabetes among women across 640 districts in India: a cross-sectional study

Research article

Hyssopus officinalis exerts hypoglycemic effects on streptozotocin-induced diabetic rats via modulating GSK-3β, C-fos, NF-κB, ABCA1 and ABGA1 gene expression

Correction

Correction to: Anti-diabetic effects of Ficus Asperifolia in Streptozotocin-induced diabetic rats

Research article

Classification of functionality of people with diabetic peripheral neuropathy based on international classification of functioning, disability and health Core set (ICF-CS) of diabetes mellitus

Review article

Anti-diabetic effects of Ficus Asperifolia in Streptozotocin-induced diabetic rats

Review article

Mediterranean diet for patients with non-alcoholic fatty liver disease, a systematic review and meta-analysis of observational and clinical investigations
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits